The Phase II trial for an Israeli COVID drug saw some 29 out of 30 patients, moderate to serious, recover within days.
Damn Jews.
Damn Jews.
COVID: 90% of patients treated with new Israeli drug discharged in 5 days
The Phase II trial for an Israeli COVID drug saw some 29 out of 30 patients, moderate to serious, recover within days.
www.jpost.com